COMPLETED

Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To evaluate if utilizing Telehealth medicine for access to HIV PrEP will engage more Black and Latino Men who have sex with Men (MSM)

Official Title

Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"

Quick Facts

Study Start:2022-07-19

Study Completion:2025-03-21

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT05528653

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:MALE

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. HIV negative on any FDA approved HIV test within 10 days of starting PrEP 18 years and older 2. No medical or mental health comorbidity that would preclude participating in a clinical study as deemed by the study investigator 3. Able to understand and sign consent in English or with other language interpreter 4. Able to stay in the state catchment area of the license health care provider 5. No use of PrEP for more than 30 days in the last year	1. HIV positive 2. If greater and equal to 50 years of age and Renal Glomerular Filtration Rate (GFR) \<30 mg/g 3. \<18 years of age 4. No access to Internet or devise for telehealth 5. Cis-gender Women

Inclusion Criteria

Exclusion Criteria

1. HIV negative on any FDA approved HIV test within 10 days of starting PrEP 18 years and older
2. No medical or mental health comorbidity that would preclude participating in a clinical study as deemed by the study investigator
3. Able to understand and sign consent in English or with other language interpreter
4. Able to stay in the state catchment area of the license health care provider
5. No use of PrEP for more than 30 days in the last year

1. HIV positive
2. If greater and equal to 50 years of age and Renal Glomerular Filtration Rate (GFR) \<30 mg/g
3. \<18 years of age
4. No access to Internet or devise for telehealth
5. Cis-gender Women

Contacts and Locations

Principal Investigator

Cindy Firnhaber, MD

PRINCIPAL_INVESTIGATOR

Vivent Health

Study Locations (Sites)

Vivent Health

Denver, Colorado, 80245

United States

Vivent Health

St Louis, Missouri, 63103

United States

Viventh Health

Milwaukee, Wisconsin, 53203

United States

Collaborators and Investigators

Sponsor: Vivent Health

Cindy Firnhaber, MD, PRINCIPAL_INVESTIGATOR, Vivent Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-19

Study Completion Date2025-03-21

Study Record Updates

Study Start Date2022-07-19

Study Completion Date2025-03-21

Terms related to this study

Keywords Provided by Researchers

Additional Relevant MeSH Terms

HIV Prevention